KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to 0.8.

  • Novavax's Asset Utilization Ratio rose 5858.71% to 0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.8, marking a year-over-year increase of 5858.71%. This contributed to the annual value of 0.41 for FY2024, which is 1623.36% down from last year.
  • As of Q3 2025, Novavax's Asset Utilization Ratio stood at 0.8, which was up 5858.71% from 0.77 recorded in Q2 2025.
  • Novavax's 5-year Asset Utilization Ratio high stood at 0.99 for Q2 2023, and its period low was 0.42 during Q4 2024.
  • In the last 5 years, Novavax's Asset Utilization Ratio had a median value of 0.62 in 2024 and averaged 0.63.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 50875.19% in 2021, then tumbled by 3708.54% in 2024.
  • Over the past 5 years, Novavax's Asset Utilization Ratio (Quarter) stood at 0.45 in 2021, then soared by 96.45% to 0.88 in 2022, then tumbled by 34.97% to 0.57 in 2023, then dropped by 26.8% to 0.42 in 2024, then skyrocketed by 90.74% to 0.8 in 2025.
  • Its Asset Utilization Ratio stands at 0.8 for Q3 2025, versus 0.77 for Q2 2025 and 0.88 for Q1 2025.